The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.
Category: Inflation Reduction Act of 2022
-
Obamacare Could See Big Changes in 2026
A proposed rule would restrict “eligibility, enrollment and affordability” in plans under the Affordable Care Act, health policy analysts say.
-
Clean Energy Was Lifting Manufacturing. Now Investment Is in Jeopardy.
With the Trump administration reversing support for low-carbon power, the business case for making wind, solar and electric vehicle parts gets weaker.
-
Medicare Doesn’t Pay for Everything: How to Bridge the Cost Gap
Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade-offs.
-
It’s Time to Shop for Medicare, and 2025 Brings Big Changes
A bumper crop of revisions, including a stronger drug benefit, means the plan you enrolled in for 2024 may not be the best fit next year.
-
Why GM’s Mary Barra Still Believes in EVs, Despite Slow Sales
Mary Barra, G.M.’s chief executive, said that the company had fixed battery-manufacturing problems and that its electric vehicles would soon be profitable.
-
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
-
E.V. Tax Credits Are a Plus, but Flaws Remain, Study Finds
The Inflation Reduction Act was a compromise between competing priorities. Evaluating the law on the effectiveness of the $7,500 tax credit for E.V.s is tricky.
-
Ohio Reaps Benefits From a Climate Law JD Vance Repeatedly Attacks
Former President Donald J. Trump has called for clawing back unspent funds included in the Inflation Reduction Act, President Biden’s landmark climate bill. That could have adverse impacts in Ohio.
-
Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums
Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris.
